|
ASOThera:
Developing new therapies for orphan diseases.
Autoimmune Therapeutics, Inc.:
Developing orally-available drug candidates to treat autoimmune disease, with initial focus on rheumatoid arthritis, based on proprietary small molecule scaffolds and pharmeceutical leads that inhibit macrophage migration inhibitory factor.
Certerra, Inc.:
Contract research organization, with specialty in central nervous system, based on single neuron-level monitoring of mamalian brains.
Cirrus Health:
Electronic discharge system to improve doctor patient communications.
DepYMed:
Joint venture between CSHL and Ohr Pharmaceuticals (Nasdaq: OHRP) to develop a drug for obesity, diabetes and HER2 cancer based on trodusquemine and related analogs.
Envisagenics, Inc.:
Big data software solution that significantly reduces uncertainty and time to market for drugs under development.
TheraSource, LLC:
Developing protein/peptide-based drugs based on MFG-E8 for inflammatory diseases, including sepsis, hemorrhagic shock, ischemia/reperfusion-induced injury, stroke, acute radiation syndrome, rheumatoid arthritis, and inflammatory bowel disease.
| 
